These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4436949)

  • 41. [Antibacterial activity of a sulfonamide combination (Kelfiprim) in some otorhinolaryngological diseases].
    Serra A; Tringali G; Toscano MA; Gismondo MR; Piaia F
    G Clin Med; 1980 Dec; 61(12):906-18. PubMed ID: 7215739
    [No Abstract]   [Full Text] [Related]  

  • 42. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of therapeutic results in acute infections in children using Chloromycetin Sol].
    Nakazawa S; Oka S; Oishi H; Arai K; Yamagishi M
    J Antibiot B; 1967 Apr; 20(2):147-51. PubMed ID: 5299157
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and pharmacological evaluation of cephapirin sodium (BL-P-1322) in infants and children (cephapirin in pediatric patients).
    Khan AJ; Pryles CV
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):198-204. PubMed ID: 4633280
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical considerations on the topical use of benzidamine hydrochloride].
    Porchia I
    Valsalva; 1970 Aug; 46(4):176-90. PubMed ID: 5280147
    [No Abstract]   [Full Text] [Related]  

  • 46. [Zinnat in ambulatory treatment of acute pharyngitis and otitis media in adult patients].
    Olszewski J; Zalewski P; Markucki S; Schmidt J
    Otolaryngol Pol; 1997; 51 Suppl 25():161-4. PubMed ID: 9757682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children.
    Gordon RC; Barrett FF; Clark DJ; Yow MD
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):398-406. PubMed ID: 4996227
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: Cephalosporins in otitis media.
    McLinn SE
    Can Med Assoc J; 1976 Jan; 114(1):13-4. PubMed ID: 1253025
    [No Abstract]   [Full Text] [Related]  

  • 49. [Fundamental and clinical studies on Minocycline Syrup against otorhinolaryngological infections].
    Iwazawa T
    Jpn J Antibiot; 1973 Apr; 26(2):97-103. PubMed ID: 4542542
    [No Abstract]   [Full Text] [Related]  

  • 50. Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses.
    Sanders WE; Johnson JE; Taggart JG
    N Engl J Med; 1974 Feb; 290(8):424-9. PubMed ID: 4811017
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical evaluation of long-acting preparation of cephalexin (S-6436) in the treatment of acute tonsillitis and acute otitis media--a double blind study (author's transl)].
    Baba S; Ito H; Tsukiyama M; Iwata S; Nishimura T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):286-302. PubMed ID: 411841
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical application of cephalexin suspension in the field of pediatrics].
    Kobayashi Y
    Jpn J Antibiot; 1969 Oct; 22(5):383-6. PubMed ID: 4903721
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical effect of a cephalosporin derivative, cefotiam, on otorhinolaryngologic infections].
    Baba S; Wada K; Hatano T; Kinoshita H; Sugimori H; Sasaki T; Miyano K; Maruyama H; Takimoto I; Inafuku S
    Jpn J Antibiot; 1983 Oct; 36(10):2693-710. PubMed ID: 6325739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies on ceftazidime in the pediatric field].
    Aoyama R; Waga S; Ohnishi A; Izumi Y; Kuronuma T; Kakizaki Y; Nagata K; Kudo M; Okaniwa S; Sawaguchi H
    Jpn J Antibiot; 1984 Mar; 37(3):349-54. PubMed ID: 6376848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical evaluation of cefsulodin for the infection caused by P. aeruginosa in otorhinolaryngological field].
    Sugita R; Kawamura S; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1982 Dec; 35(12):2825-30. PubMed ID: 7182536
    [No Abstract]   [Full Text] [Related]  

  • 56. [Basic and clinical evaluation on clindamycin palmitate in otorhinolaryngological field infection (author's transl)].
    Iwasawa T
    Jpn J Antibiot; 1973 Aug; 26(4):393-9. PubMed ID: 4542676
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anerobic infections in otolaryngology (author's transl)].
    Mann W; Pelz K
    Laryngol Rhinol Otol (Stuttg); 1981 Jul; 60(7):355-8. PubMed ID: 7047954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [ORL infections. 10th consensus conference on anti-infectious therapeutics. Under the collaboration of the French Societies of Infectious Diseases, of ORL and of Pediatrics].
    Arch Pediatr; 1997 Feb; 4(2):188-94. PubMed ID: 9097834
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug eruptions in children with ENT infections.
    Rallis E; Balatsouras DG; Kouskoukis C; Verros C; Homsioglou E
    Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):53-7. PubMed ID: 15978677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of cephapirin in the field of oral surgery (author's transl)].
    Kawashima M; Takahashi M
    Jpn J Antibiot; 1978 Jun; 31(6):310-4. PubMed ID: 682367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.